{HEAD ~ A pharmaceutical composition} comprising {TAIL ~ at least one pharmaceutically acceptable carrier} or adjuvant and an effective TNF α release inhibiting amount of a substituted 2,4 imidazolidinedione compound corresponding to the formula I ##STR24## wherein R1 represents C1 6 alkyl or C3 6 cycloalkyl 
{ HEAD ~ A pharmaceutical composition } comprising { TAIL ~ at least one pharmaceutically acceptable carrier } or adjuvant and an effective TNF α release inhibiting amount of a substituted 2,4 imidazolidinedione compound corresponding to the formula I # # STR24 # # wherein R1 represents C1 6 alkyl or C3 6 cycloalkyl
HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH